|
PPIL4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.56059999999458E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.57266999999406E-05 |
| Normal-vs-Stage2 |
1.101970E-03 |
| Normal-vs-Stage3 |
6.456700E-03 |
| Normal-vs-Stage4 |
6.497400E-01 |
| Stage1-vs-Stage2 |
6.990200E-01 |
| Stage1-vs-Stage3 |
1.597160E-01 |
| Stage1-vs-Stage4 |
3.731700E-02 |
| Stage2-vs-Stage3 |
4.363200E-01 |
| Stage2-vs-Stage4 |
1.342650E-01 |
| Stage3-vs-Stage4 |
2.676400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.75690000000706E-05 |
| Normal-vs-AfricanAmerican |
5.7635999999972E-05 |
| Normal-vs-Asian |
2.447700E-02 |
| Caucasian-vs-AfricanAmerican |
9.593600E-01 |
| Caucasian-vs-Asian |
9.280600E-01 |
| AfricanAmerican-vs-Asian |
9.356400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.96010000008684E-07 |
| Normal-vs-Female |
3.277200E-03 |
| Male-vs-Female |
2.364500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.832290E-04 |
| Normal-vs-Extreme_Weight |
3.29419999944847E-07 |
| Normal-vs-Obese |
1.379080E-03 |
| Normal-vs-Extreme_Obese |
1.075510E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.705600E-01 |
| Normal_Weight-vs-Obese |
4.142000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.352200E-01 |
| Extreme_Weight-vs-Obese |
4.088400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.316800E-01 |
| Obese-vs-Extreme_Obese |
7.830000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.038200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.115970E-03 |
| Normal-vs-Age(61-80Yrs) |
2.95149999995914E-07 |
| Normal-vs-Age(81-100Yrs) |
3.77350000000387E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.511200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.865900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.209900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.237000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.745600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.171600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.52280000223593E-08 |
| Normal-VS-Type2 PRCC |
1.61140999999088E-05 |
| Normal-VS-KIRP CIMP |
5.066400E-01 |
| Normal-VS-Unclassified PRCC |
9.433400E-04 |
| Type1 PRCC-VS-Type2 PRCC |
9.878400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.06789999999524E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
5.154000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.778500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
6.511000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.616800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.43210000524974E-08 |
| Normal-vs-N1 |
8.488400E-01 |
| Normal-vs-N2 |
3.224800E-03 |
| N0-vs-N1 |
1.74539999999723E-05 |
| N0-vs-N2 |
7.301800E-01 |
| N1-vs-N2 |
4.461600E-02 |
|
|
